# Wei-Wu He

> Wei-Wu He is a scientist, inventor, entrepreneur and investor who serves as Executive Chairman and CEO of Human Longevity, Inc., the San Francisco Bay Area precision-health company that pairs whole-genome sequencing with advanced imaging and blood analytics to catch age-related disease early. Trained as a molecular biologist at Baylor College of Medicine with an MBA from Wharton, he was among the first scientists at Human Genome Sciences before building OriGene Technologies into a major research-tools business. Over three decades he has founded or funded dozens of biotech companies through his venture fund Emerging Technology Partners, and he now channels that experience into the science of extending healthy human lifespan.

- **Role:** Chairman and CEO at Human Longevity, Inc.
- **Organizations:** Human Longevity, Inc., OriGene Technologies, Inc., Emerging Technology Partners, LLC, Human Genome Sciences
- **Nationality:** American
- **Education:** Ph.D. in Molecular Biology, Baylor College of Medicine, M.B.A., The Wharton School, University of Pennsylvania
- **Known for:** Founded or funded dozens of biotechnology companies across genomics and precision medicine, Author of more than 90 peer-reviewed academic papers, Co-inventor on more than 30 issued patents

## Career timeline

- **1990s** — Research fellow at Massachusetts General Hospital and the Mayo Clinic
- **1990s** — Among the first scientists at Human Genome Sciences
- **2000** — Founded Emerging Technology Partners, LLC, a life-sciences venture fund, as General Partner
- **2000s** — Led OriGene Technologies, Inc. as CEO; remains Chairman of the Board
- **2019** — Became Executive Chairman of Human Longevity, Inc. (July 2019)
- **2024** — Human Longevity raised additional funding; He leads as Chairman and CEO

## Achievements

- Founded or funded dozens of biotechnology companies across genomics and precision medicine
- Author of more than 90 peer-reviewed academic papers
- Co-inventor on more than 30 issued patents
- Built OriGene Technologies into a leading provider of research tools and full-length human cDNA collections
- Established Emerging Technology Partners as a life-sciences venture fund in 2000
- Leads Human Longevity, integrating whole-genome sequencing, advanced imaging and blood analytics for early disease detection

## Latest updates

- **2024-08** — Human Longevity, Inc. raised additional funding as it continued expanding its precision-health and preventive-diagnostics platform.
- **2026-01** — Listed as a speaker at the 2026 Precision Medicine World Conference (Silicon Valley).

## Links

- Website: https://humanlongevity.com
- LinkedIn: http://www.linkedin.com/in/wei-wu-he-ph-d-he-him-b6957313
- YouTube: https://www.youtube.com/watch?v=eYAVIgj-SaQ

---

Profile page: https://yespress.io/wei-wu-he
Published by YesPress — https://yespress.io
Last updated: 2026-07-22